Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
VERTEX PHARMACEUTICALS INCORPORATED <VRTX.O>: STIFEL RAISES TARGET PRICE TO $563 FROM $500

VERTEX PHARMACEUTICALS INCORPORATED <VRTX.O>: STIFEL RAISES TARGET PRICE TO $563 FROM $500

ReutersReuters2026/11/03 11:49
By:Reuters
VERTEX PHARMACEUTICALS INCORPORATED
: STIFEL RAISES TARGET PRICE TO $563 FROM $500
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!